Referral to the Rooyagen PRP Kit in the Clinical Guidelines of the American Academy of ...


Referral to the Rooyagen PRP Kit in the Clinical Guidelines of the American Academy of Orthopedic Surgeons (AAOS)2021

 

The latest clinical guideline from the American Academy of Orthopedic Surgeons (AAOS) was published in August 2021 based on a systematic review of studies examining the non-arthroplasty treatment of osteoarthritis of the knee in adults. As the most comprehensive clinical guide, this guideline reviews all non-surgical techniques for treating osteoarthritis and provides recommendations for integrating current evidence and clinical practice based on medical records. This guide is a reference for use by trained physicians and physicians who manage the treatment of osteoarthritis of the knee and also serves as a source of information for developers and users of clinical practice guidelines and manufacturers of drugs and medical devices.

Of all the methods, including canes and braces, supplements to interventions, gel, corticosteroids and PRP, this 126-page instruction is detailed, and fortunately, new methods such as PRP have been seriously considered and approved by the American association of Hip and Knee surgery (AAHKS).

    It is a matter of pride that the PRP section has been referenced 4 times to the studies of the Rooyagen PRP kit. Out of about 20 world-class studies that were able to enter this study, 4 cases were referred to Rooyagen Kit. On pages 60 to 62 of the report, references to Nos. 446, 447, 448 and 453 refer to studies that have used the Rooyagen PRP kit for treatment. More interestingly, the Rooyagen kit is one of the high-performance kits for PRP processing, and as a result, the level of study is raised.

In the following, the link of the mentioned instruction will be available to you dear ones for further reading:

https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/oak3cpg.pdf




News and Events


Extending the standards of quality management system and production of PRP Rooyagen ...
Extending the standards of quality management system and production of PRP Rooyagen ...
Read More
Re-Meeting FDA Requirements to Produce Rooyagen PRP Kit
Re-Meeting FDA Requirements to Produce Rooyagen PRP Kit
Read More
Referral to the Rooyagen PRP Kit in the Clinical Guidelines of the American Academy of ...
Referral to the Rooyagen PRP Kit in the Clinical Guidelines of the American Academy of ...
Read More
2th Debatable topic on obstetrics gynecology and infertility
2th Debatable topic on obstetrics gynecology and infertility
Read More
7th International Congress and Student award in Reproductive Medicine, Yazd
7th International Congress and Student award in Reproductive Medicine, Yazd
Read More
International Congress of cosmetic and Laser ...
International Congress of cosmetic and Laser ...
Read More
Stunning treatment of infertility with Platelet enriched (Lympho-PRP in IVF)
Stunning treatment of infertility with Platelet enriched (Lympho-PRP in IVF)
Read More

About us

  • Rooyagen brand (ROOYA GEN) owned by Aria Mabna TashKhis -Knowledge based -Company, was born in 2010. Rooyagen, while entering the field of medical device production, became the first platelet processing and concentrating (PRP) kit in Iran after obtaining the relevant licenses. The first product in the Rooyagen PRP kit was for musculoskeletal use.

  • From the beginning of 2013, Rooyagen was able to launch another product in the field of skin rejuvenation and hair loss treatment. One of the honors of the Rooyagen brand is active participation in scientific and academic forums. The products of this brand have been cited in several (more than 50) scientific articles and have received over 1000 referral citation from scientific studies.

  • Following the path of research and development in 2016, another product of Rooyagen was produced for the treatment of chronic wounds. This kit was produced as a platelet gel with high durability and Sustain release technology and brought brilliant results. Accompaniment of professors of Tehran University of Medical Sciences - Shariati Hospital was published and is now available in clinics for the treatment of diabetic wounds and other chronic wounds

  • Simultaneously with achieving promising results for the treatment of infertility worldwide, Rooyagen product for infertility uses such as recurrent miscarriage and thin endometrium, has successfully passed its research and development stages and with the cooperation of professors of Taleghani Hospital- Beheshti University of Medical Sciences It has been clinically proven and its results have been published in authoritative ISI articles. Fortunately, today most infertility centers in the country are using this product to help infertile couples. we are proud continuing this path with your support and enthusiasm for new services to patients in need ...

  • Be Part
    Of Our
    Story!

Unit 1, No.11,setayesh, satarkhanSt., Tehran.

+98 66512800

Info[@]Rooyagen.com


{{msg}}